TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease
- Lee, Eun Ji; Seo, Eunjeong; Kim, Jin Won; Nam, Sun Ah; Lee, Jong Young; Jun, Jaehee; Oh, Sumin; Park, Minah; Jho, Eek-hoon; Ryu, Kyung Hyun; Park, Jong Hoon; Kyun, Yong
- Issue Date
- National Academy of Sciences
- C-myc; Polycystic kidney; TAZ
- Proceedings of the National Academy of Sciences of the United States of America, v.117, no.46, pp.29001 - 29012
- Journal Title
- Proceedings of the National Academy of Sciences of the United States of America
- Start Page
- End Page
- Autosomal-dominant polycystic kidney disease (ADPKD) is the most common genetic renal disease, primarily caused by germline mutation of PKD1 or PKD2, leading to end-stage renal disease. The Hippo signaling pathway regulates organ growth and cell proliferation. Herein, we demonstrate the regulatory mechanism of cystogenesis in ADPKD by transcriptional coactivator with PDZ-binding motif (TAZ), a Hippo signaling effector. TAZ was highly expressed around the renal cyst-lining epithelial cells of Pkd1-deficient mice. Loss of Taz in Pkd1-deficient mice reduced cyst formation. In wild type, TAZ interacted with PKD1, which inactivated β-catenin. In contrast, in PKD1-deficient cells, TAZ interacted with AXIN1, thus increasing β-catenin activity. Interaction of TAZ with AXIN1 in PKD1-deficient cells resulted in nuclear accumulation of TAZ together with β-catenin, which up-regulated c-MYC expression. Our findings suggest that the PKD1–TAZ–Wnt–β-catenin–c-MYC signaling axis plays a critical role in cystogenesis and might be a potential therapeutic target against ADPKD. © 2020 National Academy of Sciences. All rights reserved.
- Files in This Item
Go to Link
- Appears in
- 이과대학 > 생명시스템학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.